HEMOPATCH
DeviceApplied according to the current instruction for use (IFU). According to the IFU, a maximum of 7 Hemopatch 45 x 90 mm patches can be used in adults.
NCT Number: NCT03450265
This study is a randomized, controlled study, with the primary objective to demonstrate non-inferiority of Hemopatch compared to TachoSil in postoperative air leak duration after pulmonary resection, and with the secondary objective of evaluating the safety of Hemopatch compared to TachoSil.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Baxter Investigational Site, Catania, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Preoperative-
Intraoperative-
Exclusion criteria
Preoperative-
Intraoperative-
Applied according to the current instruction for use (IFU). According to the IFU, a maximum of 7 Hemopatch 45 x 90 mm patches can be used in adults.
Applied according to the current instruction for use (IFU).
Time frame: Day 1 to Day 30
Time frame: Day 1
Time frame: Day 5 to Day 30
Time frame: Day 1 to Day 30
Type of procedures include chest drainage, re-operation, respiratory assistance, and blood transfusion
Time frame: Day 1 to Day 30
Time frame: Day 1
Time frame: Day 1 to Day 30
Time frame: Day 1 to Day 30
Time frame: Day 1 to Day 30
Pre-defined AEs include Pneumothorax, Bronchopleural fistula, Emphysema (subcutaneous and mediastinal), Pleural effusions, Postoperative respiratory failure, Empyema, Allergic reactions in reasonable temporal relationship with the product application
Time frame: Day 1
Baxter Healthcare Corporation
Industry
A Randomized, Controlled, Non-inferiority Study to Evaluate the Efficacy and Safety of Hemopatch Compared to TachoSil in Preventing or Reducing Postoperative Air Leaks After Pulmonary Resection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06544200
Air Leak From Lung, Lung Cancer Stage I
Padua, Italy
View Trial DetailsNCT03021369
Air Leak From Lung
Bad Nauheim, Germany
View Trial DetailsNCT03056716
Air Leak From Lung, Post Procedural Persistent Drain Fluid
Bursa, Yildirim, Turkey (Türkiye)
View Trial DetailsNCT07350265
Air Leak From Lung, Lung Surgery
Antony, France
View Trial Details